Yes, with conditions: for a first depressive episode held in remission for nine months, NU675's Unit 1 post supports a gradual taper, a monitoring calendar and named restart criteria. Searches like "nu 675 unit 1 assignment example", "nu675 unit 1 sample" and "nu675 unit 1 example" land here.
What a finished NU675 Unit 1 discussion board post looks like
Three paragraphs and a short reply, near 390 words with three sources. Its first paragraph takes the position and lists the facts beneath it: one episode, no prior history, a QIDS-SR of [4] at each of the last three visits, and remission held past the six-month minimum that NICE's 2022 depression guideline describes before stopping is considered. Paragraph two then weighs the strongest counterevidence, the ANTLER trial (Lewis et al., 2021), in which primary care patients who stopped their antidepressant relapsed more often over a year than those who continued, and notes that most participants had already been through more than one episode. The third paragraph sets conditions: a taper across [several weeks], contact at [two] and [six] weeks after the last reduction, her own early signs listed, and a restart rule.
How a NU675 Unit 1 example is structured
Position first, because the prompt asks whether, and a reader should know the answer before the reasoning. Each supporting fact is tied to a relapse risk factor the literature names, so the case for stopping is built from the absence of those factors rather than from her wish alone: no prior episodes, no residual symptoms, no severe or psychotic features, and a stable home and workload. The counterevidence is not buried. ANTLER is described accurately, its result stated without softening, and its population compared with hers in one careful sentence. Conditions follow as a short list anyone could audit later, which turns a permission into a plan. Her preference appears as a reason, not the reason. The reply picks a classmate who argued for indefinite continuation and asks which history would make them agree to a trial off medication.
A yes stated up front
The opening sentence answers the board's question for this patient before any evidence appears. Leading with the position lets a reader test every later sentence against it, and it prevents the familiar post that surveys both sides and never lands.
Risk factors, counted
Prior episodes, residual symptoms, severity and life stability are each checked against her history. Because the case for stopping rests on what is absent, the post names the sources that identify those factors instead of asserting that she is low risk.
The trial that argues back
ANTLER's finding that stopping raised relapse over fifty-two weeks is given full weight. The post then observes the difference in history between the trial's participants and a first-episode patient, without claiming the trial has nothing to say about her.
Conditions an auditor could check
Taper length, contact dates after the last reduction, her personal early signs and the threshold for restarting are written as items. A reader returning in six months could tell from the list alone whether the plan had been followed.
Preference weighed, not obeyed
Her wish to be medication-free counts in the reasoning and is stated as such. The post does not treat it as decisive, and it notes that her preference would carry less weight if her history included a severe or recurrent course.
Where marks go in NU675 Unit 1
Proportion is what this board rewards: a position sized to the history behind it. Arguing that every remitted patient should stop, or that none should, ignores the risk factors that separate one case from another, and posts built on either slogan score poorly. Handling of ANTLER is checked closely: citing it as proof that stopping is dangerous for everyone overstates it, while omitting it entirely suggests the strongest counterevidence went unread. A permission to stop with no taper, no follow-up dates and no restart rule is marked as a plan missing its working parts. Credit thins when the patient's wish becomes the whole argument, since preference alone does not answer a clinical question. Unbracketed amounts and a misdated guideline draw brief comments, as does a classmate response that only restates the original post.
Get a NU675 Unit 1 example written to your instructions
Paste the NU675 Unit 1 prompt, noting whether it hands you a patient or asks you to choose one, and include the rubric. Built on those instructions, a first custom post comes free within 24-48h, offering a position on stopping, the counterevidence weighed honestly, and conditions a reader could check later.
NU675 Unit 1 questions, answered
How long after remission should a first-episode patient continue treatment?
Guidelines commonly describe a continuation period of roughly six to nine months after remission before stopping is considered, with longer treatment when relapse risk is higher. Cite the guideline you use and its year. The stronger posts then tie the number to the person: the severity of the episode, residual symptoms and stressors ahead can all argue for waiting longer.
Does the post have to discuss discontinuation symptoms?
Briefly, yes, because a taper plan that ignores them leaves a gap. Note that stopping some antidepressants can produce physical and emotional symptoms, that a gradual reduction lowers that risk, and that the plan will distinguish them from a return of depression. Keep the detail proportionate; a long paragraph on withdrawal can crowd out the continuation argument itself.
Can the post disagree with the patient's wish to stop?
It can, if the history supports continuing. Say why, respectfully, and describe what would make stopping reasonable later, such as a longer remission or a change in stressors. A post that simply overrules the patient reads poorly; one that explains the risk and leaves a path open shows the shared decision-making the course expects.